Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arturo Molina, MD
Sutro Biopharma
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Arizona Oncology Associates, Pc--Hope Division
Tucson, Arizona, United States
- City of Hope Medical Center
Duarte, California, United States
- Uc Davis Comprehensive Cancer Center
Sacramento, California, United States
- Univeristy of California San Francisco Hdf Comprehensive Cancer Center
San Francisco, California, United States
- Rocky Mountain Cancer Center
Aurora, Colorado, United States
- Emory University Winship Cancer Institute
Atlanta, Georgia, United States
- Indiana University Health Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- University of Kansas Cancer Center
Fairway, Kansas, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Henry Ford Cancer Institute
Detroit, Michigan, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Weill Cornell Medicine
New York, New York, United States
- Willamette Valley Cancer Institute and Research Center
Eugene, Oregon, United States
- Texas Oncology
Austin, Texas, United States
- Texas Oncology - Baylor Charles A. Sammons Cancer Center
Dallas, Texas, United States
- Ut Southwestern Medical Center
Dallas, Texas, United States
- Ut Health San Antonio
San Antonio, Texas, United States
- Virginia Cancer Specialists
Fairfax, Virginia, United States
- West Virginia University
Morgantown, West Virginia, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Feb 2018
- Primary completion
- 15 Feb 2024
- Completion
- 15 Mar 2024
- Last update posted
- 11 Jun 2024
- Registered enrollment
- 70
- Registry id
- NCT03424603
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.